News
-
According to Bausch Health and Glenmark, Health Canada has approved Ryaltris olopatadine / mometasone furoate nasal spray for the treatment of seasonal allergic rhinitis in people aged 6 and older. Bausch Health acquired the Canadian rights… Read more . . .
-
On a form 8-k filed with the US Securities and Exchange Commission (SEC), United Therapeutics reported the following: “On September 20, 2022, United Therapeutics Corporation (the Company) announced the termination of the PERFECT clinical study… Read more . . .
-
OINDP development specialist Nanopharm, which was acquired by Aptar Pharma in 2019, and functional respiratory imaging (FRI) company Fluidda are teaming up to help sponsors of ANDAs for inhaled drugs for asthma and COPD avoid… Read more . . .
-
CDMO MedPharm has announced that it will provide formulation and delivery development services for Swiss startup Mosanna Therapeutics’ MOS-118 potassium channel blocker, with the goal of advancing a nasal spray formulation into clinical development for… Read more . . .
-
Device maker H&T Presspart has partnered with CRO OzUK in order to offer complete development services for metered dose inhalers to H&T Presspart customers. OzUK, which specializes in MDIs and other liquid-based OINDPs, will provide formulation… Read more . . .
-
Synairgen announced that it will present data from the Phase 3 SPRINTER trial of its SNG001 nebulized interferon-beta-1a in hospitalized COVID-19 patients at an upcoming meeting showing that treatment with SNG001 reduced symptoms of long… Read more . . .
-
Satsuma Pharmaceuticals announced that data from a portion of the Phase 3 ASCEND trial of the company’s STS101 dihydroergotamine (DHE) nasal powder where STS101 was delivered via a second generation device for the treatment of… Read more . . .
-
Startup Moat Biotechnology announced the initiation of a funding round led by Cortado Ventures that aims to raise up to $20 million for continued development of the company’s intranasal vaccine against COVID-19. According to the… Read more . . .
-
The US Department of Justice has announced that Akorn will pay $7.9 million to settle a case related to submission of false claims to Medicare Part D after the company continued to sell three products,… Read more . . .
-
Yale University spinout RIGImmune, which has been developing stemloop RNA (SLR) therapeutics, announced that it has acquired biotech Subintro, which has been working on antivirals for RNA virus-caused respiratory infections. The company will now develop… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan